The Pathogenesis, Complications and Therapeutic Strategy for Hepatitis C Virus-associated Insulin Resistance in the Era of Anti-viral Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|5|3|147-157

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.5, Iss.3, 2010-09, pp. : 147-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rates and predictors of response to anti‐viral treatment for hepatitis C virus in HIV/HCV co‐infection in a nationwide study of 619 patients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1373-1384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C Virus-Associated Extrahepatic Manifestations: A Review

By Sène Damien   Limal Nicolas   Cacoub Patrice  

Metabolic Brain Disease, Vol. 19, Iss. 3-4, 2004-12 ,pp. : 357-381

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Hepatitis B Virus-Associated Nephropathy

By  

Nephron Clin Pract, Vol. 119, Iss. 1, 2011-06 ,pp. : c41-c49

Karger

Access to resources Recommend Favorite

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1365-1372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

John Wiley & Sons Inc

Access to resources Recommend Favorite